Egle Therapeutics at EADV 2026
Dates : 30 September – 3 October 2026
Location : Vienna, Austria
Egle Therapeutics will present new Phase 1 data for EGL-003 as an ePoster at the 35th Congress of the European Academy of Dermatology and Venereology (EADV), Europe’s leading congress in dermatology and venereology.
Learn more about the event : https://eadv.org/congress/
Abstract / ePoster: AS-3660 / P1719
Title: EGL-003 First in Human Study: An IL-2 Mutein inducing potent and selective amplification of Treg with preferential activation of effector/memory skin homing Tregs